导电系统节奏为心脏再同步治疗心力衰竭与减少喷射分数的心脏衰竭
Saurab Karki1, Pallavi Lakra2, Kaushik Kumar3
1Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, MD 21237, USA.
Journal of clinical medicine
|February 13, 2025
概括
导电系统节奏 (CSP) 与传统的双心室节奏 (BVP) 相比,为心脏再同步治疗提供了更生理的方法. 通过CSP进行左捆分支区域节奏 (LBBAP) 显示出优异的结果,减少心力衰竭住院和死亡率.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭管理的管理
背景情况:
- 室腔失调影响大多数心力衰竭患者,通常用双室腔节奏 (BVP) 治疗.
- 很大一部分患者 (约30%),表现出低于最佳的反应甚至BVP的恶化.
- 导电系统节奏 (CSP),包括他的捆绑节奏 (HBP) 和左捆绑分支区域节奏 (LBBAP),提供了一个更生理的替代方案.
研究的目的:
- 审查和比较各种CSP技术用于心脏再同步治疗 (CRT) 心力衰竭与减少喷射率 (HFrEF).
- 根据目前的文献,分析CSP与传统BVP的有效性,直到2023年.
主要方法:
- 系统审查2023年之前发表的文献.
- 包括八项研究:两项试验和五项观察性研究.
- 总患者队列为2841个人.
主要成果:
- 无论是BVP还是CSP,都改善了结果,包括NYHA类,QRS持续时间和左心室喷射率.
- 由于其生理性质和同步心室激活,CSP表现出更明显的改善.
- 与BVP相比,左捆支部区域节奏 (LBBAP) 显示出优异的结果,降低了心力衰竭住院和全因死亡率.
结论:
- 导电系统节奏是HFrEF患者的有效CRT策略.
- 左捆分支区域步调比传统的BVP提供了显著的优势,改善了临床结果和生存率.
- CSP代表了CRT在心力衰竭管理中的有希望的进步.
相关概念视频
Conduction System of the Heart
4.3K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
4.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Electrophysiology of Normal Cardiac Rhythm
2.0K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
2.0K
Disturbances in Heart Rhythm
884
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
884


